Skip to main content
Main analysis: Diplomat 2025: Sales Still Grew, but 2026 Already Looks Like a Capital Test
ByMarch 27, 2026~10 min read

Diplomat: Where the Cash Gets Stuck and How Working Capital Is Eating the Growth

The main article already argued that Diplomat’s growth is not turning cleanly into cash. This follow-up isolates why: receivables and inventory grew faster than supplier funding, the July 2025 equity raise added NIS 99.6 million net yet did not create a new cash cushion, and on an all-in basis operating cash did not cover leases, capex and dividends.

The main article already established that Diplomat is still growing, but the cash is not arriving with the growth. This follow-up isolates only that issue: where the money actually gets trapped, what the July 2025 equity raise really solved, and what still depends on outside funding.

Two cash frames matter here. The first is cash conversion, meaning what is left from profit after working capital, tax and interest. The second is all-in cash flexibility, meaning how much cash is really left after lease cash, capex, dividends and strategic uses. At Diplomat both frames point to the same place: the active bottleneck is no longer sales. It is the cash locked on the way.

Four points frame the picture:

  • Positive working capital is not a cash cushion. At the end of 2025 the group showed NIS 528.7 million of positive working capital, but only NIS 54.8 million of cash and cash equivalents.
  • 2025 absorbed NIS 106.9 million inside working capital. Receivables rose by NIS 86.8 million and inventory by NIS 68.8 million, while the increase in suppliers offset only NIS 53.0 million.
  • The July raise bought time, not room. The company raised NIS 99.6 million net, yet ended the year with NIS 22.8 million less cash and only NIS 20.2 million less bank credit.
  • On the all-in view, operating cash no longer covers the ordinary uses. NIS 74.0 million of operating cash flow did not cover NIS 73.5 million of total lease cash outflow, NIS 84.0 million of PP&E purchases and NIS 66.2 million of dividends.

Where the bridge from profit to cash breaks

The central story of 2025 is not that profit disappeared. It did not. Net income reached NIS 114.9 million. But the path from profit to cash became much harder. Cash flow from operations came in at only NIS 74.0 million, after negative adjustments of NIS 40.9 million from net income.

The root of the gap sits in working capital. Changes in assets and liabilities alone pulled NIS 106.9 million out of cash flow. That is no longer a technical detail. It is a funding engine in its own right.

What got absorbed inside working capital in 2025

That number matters because it shows that higher sales were not funded out of supplier credit alone. Even after the company pulled in another NIS 53.0 million through suppliers and service providers, it still used much more cash in receivables and inventory. In fact, even before bringing inventory into the equation, the gap between average customer credit and average supplier credit widened to about NIS 151.9 million in 2025 from about NIS 94.4 million in 2024.

One of the few positive cash offsets is also not as clean as it first looks. Other receivables fell by NIS 24.3 million, but most of that came from a roughly NIS 29 million decline in supplier participation in discounts and related receivables, driven by lower sales and a working-model change in South Africa and New Zealand. That is not a release of cash created by better collection discipline. It is simply less money still sitting against suppliers.

There is also a quality layer in receivables that deserves attention. Most of the balance is still not overdue, NIS 407.5 million out of NIS 510.6 million before the allowance, so this is still mainly a scale issue rather than a full credit event. But the tail did stretch: balances more than 120 days overdue rose to NIS 5.7 million from NIS 2.3 million, balances 91 to 120 days overdue rose to NIS 15.2 million from NIS 11.6 million, and the allowance for doubtful accounts increased to NIS 8.7 million from NIS 6.5 million. This is not a collection blow-up, but it is no longer a clean receivables picture either.

The territorial map shows where the cash cycle is longest

The problem is not evenly distributed across the footprint. In absolute shekels, Israel is the heart of the story. In terms of credit structure, Georgia is the harshest territory. New Zealand enjoys better supplier terms, but still carries heavy inventory. Cyprus is smaller, yet customer days already rose to 55. South Africa looks easier than the consolidated headline, but even there inventory grew partly because of a missed sales forecast.

Customer, inventory and supplier days by territory in 2025
Territory2025 working capital, NIS millionInventory daysCustomer daysSupplier daysWhat stands out
Israel358.9864544Nearly 68% of group working capital. Suppliers barely offset the inventory and receivables burden
South Africa63.4382117A shorter cycle, but inventory still rose partly because sales were below forecast
Georgia37.3539034The toughest credit profile. Customer days are far longer than supplier days
New Zealand27.9642646Supplier terms help, but inventory is still heavy and average customer credit still rose
Cyprus41.2635548A clear increase in customer days alongside relatively high inventory

That table explains why positive working capital can be misread. It is not created by excess cash. It is created by the fact that the group is holding much more receivables and inventory than suppliers are funding for it. Israel alone carries NIS 358.9 million of working capital, almost 68% of the group's NIS 528.7 million total. So even if the problem looks consolidated, the biggest cash hole still sits first in the Israeli operation.

Georgia adds a different warning. The absolute working-capital number is much smaller there, but the credit structure itself is harsher: 90 customer days against 34 supplier days and 53 inventory days. In other words, this is a territory where suppliers do not fund a reasonable part of the waiting time until cash comes in.

New Zealand shows why the territories are not identical. There, supplier days of 46 are higher than customer days of 26. That helps. But inventory still stood at 64 days and working capital still reached NIS 27.9 million. So even a relatively easier territory is not really releasing cash back into the system.

The July 2025 equity raise bought time, not a cushion

This is where one of the year's most important contradictions sits. In July 2025 Diplomat placed 2,150,538 shares with three institutional investors at about NIS 46.5 per share, for NIS 100 million gross. Net of issuance costs, NIS 99.6 million came in. The issuance represented about 7.24% of issued and paid-in capital after the deal.

On the surface, that should have materially eased the balance sheet. In practice, it mostly prevented a sharper tightening.

At year-end 2025 bank credit stood at NIS 224.5 million, only NIS 20.2 million lower than at year-end 2024. Cash was lower by NIS 22.8 million. And on an average-balance basis the picture is even sharper: average short-term credit rose to NIS 284.2 million from NIS 235.8 million in 2024, while average long-term credit fell to NIS 114.0 million from NIS 118.6 million. In other words, even after an equity raise, the funding model of the business remained shorter-dated and more dependent on working capital.

That is the point the market may miss. Equity raising is usually read as balance-sheet strengthening. Here it mostly absorbed existing pressure. The filing itself says part of the decline in Israeli bank credit came from the July proceeds, but in the same breath explains that the benefit was offset by higher working-capital needs and the investment in the Caesarea logistics center. The same pattern also appeared in New Zealand, where short-term credit increased because of higher working capital, activity purchases and the first-time consolidation of CBL.

The cash also went into very concrete uses. During the year the company paid NIS 40 million as lease advances for the Caesarea logistics-center project, spent NIS 84.0 million on PP&E, NIS 9.5 million on intangible assets, NIS 15.8 million on activity purchases and NIS 9.0 million on a company consolidated for the first time. At the same time it paid NIS 66.2 million of dividends, including NIS 56.5 million to company shareholders and NIS 9.65 million to non-controlling interests.

One more item changes the liquidity read. In 2025 the company also redeemed a long-term deposit of NIS 103 million. That move eased investing cash flow and made the visible pressure on the cash balance look smaller. Without that redemption, the cash erosion would have looked materially worse.

On the all-in cash view, operating cash no longer covers the ordinary uses

To understand the depth of the issue, it is not enough to stop at cash flow from operations. This is where the analysis has to move to all-in cash flexibility, meaning how much cash is left after the actual uses. At Diplomat that matters because leases, logistics-center investment, dividends and acquisitions are already sitting on the same cash pool.

What was left from operating cash after key cash uses in 2025

That is the core of the thesis. Once cash flow from operations is reduced by total lease-related cash outflow of NIS 73.5 million, PP&E purchases of NIS 84.0 million and dividends of NIS 66.2 million, the company is already negative by about NIS 149.6 million. And that is still before the NIS 40 million Caesarea lease advance, before NIS 15.8 million of activity purchases, before the NIS 9.0 million acquisition of the newly consolidated company and before the NIS 9.5 million investment in intangible assets.

That is why the July raise did not fix the conversion engine. It mainly prevented the gap from rolling entirely into banks and year-end cash.

The same message also runs through the interest line. The board discussion says explicitly that operating cash flow fell not only because of working capital, but also because of higher interest payments. That makes sense: once the business leans more heavily on short-term credit to fund receivables and inventory, interest stops being a footnote.

Why this matters now

The broader implication is that Diplomat can no longer be judged only by its ability to add brands, categories and territories. It now has to be judged by its ability to release cash from the existing system before layering on another growth step. The report itself highlights continued territorial expansion as a strategic goal, and after the balance-sheet date the company already signed a non-binding MOU for a distribution activity in Mexico.

That makes 2026 about more than just whether revenue can keep rising. The test is whether receivables and inventory start moving more slowly than sales, whether supplier funding keeps supporting the model without wearing down, and whether the equity raised in July 2025 turns into real flexibility rather than just another layer of time before the next capital cycle.

The thesis of this follow-up is simple: Diplomat does not suffer from a shortage of growth. It suffers from a shortage of growth turning into cash. As long as NIS 528.7 million of working capital sits against NIS 54.8 million of cash, as long as an equity raise of NIS 99.6 million does not leave a new cash cushion, and as long as operating cash does not even cover the lease, PP&E and dividend layer, the key question is no longer how much the company sells. The key question is who funds the path.

If Diplomat manages over the next two years to slow the rate of growth in receivables and inventory, rely less on short-term credit and keep the Caesarea and expansion spending under tighter discipline, the read can improve quickly. If not, even good top-line growth will keep looking like volume funded from outside rather than a business that can generate cash from within.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction